A retrospective study evaluating clinical and molecular predictors of duration of response (DoR) to immune checkpoint inhibitors (ICI) in patients with advanced non-small cell lung cancer (NSCLC).

Yahya Ibrahim,Keerthana Sankar,Seongho Kim,Amy Haddad,Hirva Mamdani

A retrospective study evaluating clinical and molecular predictors of duration of response (DoR) to immune checkpoint inhibitors (ICI) in patients with advanced non-small cell lung cancer (NSCLC).

2020

Yahya Ibrahim
Keerthana Sankar
Seongho Kim
Amy Haddad
Hirva Mamdani

e21581Background: ICI with/without chemotherapy has become the standard of care for the treatment of advanced NSCLC. Little is known about the clinical and molecular predictors of DoR to these agen...

Keywords:

Oncology
Internal medicine
in patient
immune checkpoint inhibitors
Retrospective cohort study
Pathology
non-small cell lung cancer (NSCLC)
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations